248 related articles for article (PubMed ID: 11019829)
1. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
Tyulmenkov VV; Klinge CM
Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
3. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
[TBL] [Abstract][Full Text] [Related]
4. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
5. Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta.
Vijayanathan V; Greenfield NJ; Thomas TJ; Ivanova MM; Tyulmenkov VV; Klinge CM; Gallo MA; Thomas T
Biochem Cell Biol; 2007 Feb; 85(1):1-10. PubMed ID: 17464340
[TBL] [Abstract][Full Text] [Related]
6. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
7. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
Klinge CM; Traish AM; Driscoll MD; Hilf R; Bambara RA
Steroids; 1996 May; 61(5):278-89. PubMed ID: 8738832
[TBL] [Abstract][Full Text] [Related]
8. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
9. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
Klinge CM; Traish AM; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
[TBL] [Abstract][Full Text] [Related]
12. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
15. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.
Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):413-29. PubMed ID: 9010347
[TBL] [Abstract][Full Text] [Related]
16. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor microarrays: subtype-selective ligand binding.
Kim SH; Tamrazi A; Carlson KE; Daniels JR; Lee IY; Katzenellenbogen JA
J Am Chem Soc; 2004 Apr; 126(15):4754-5. PubMed ID: 15080660
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K
Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758
[TBL] [Abstract][Full Text] [Related]
20. Interactions of synthetic estrogens with human estrogen receptors.
Nikov GN; Eshete M; Rajnarayanan RV; Alworth WL
J Endocrinol; 2001 Jul; 170(1):137-45. PubMed ID: 11431146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]